Cargando…
Emerging hepatotoxicity biomarkers and their potential to improve understanding and management of drug-induced liver injury
Biomarkers of drug-induced liver injury (DILI) are essential for the diagnosis of severe cases of DILI in clinical trials and clinical practice, but the currently used biomarker paradigm detects damage after it has occurred and has limited prognostic value. The development of new biomarker strategie...
Autores principales: | Aubrecht, Jiri, Schomaker, Shelli J, Amacher, David E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979132/ https://www.ncbi.nlm.nih.gov/pubmed/24073687 http://dx.doi.org/10.1186/gm489 |
Ejemplares similares
-
Glutamate dehydrogenase as a biomarker for mitotoxicity; insights from furosemide hepatotoxicity in the mouse
por: Church, Rachel J., et al.
Publicado: (2020) -
Serum microRNA signatures as "liquid biopsies" for interrogating hepatotoxic mechanisms and liver pathogenesis in human
por: Krauskopf, Julian, et al.
Publicado: (2017) -
Serum glutamate dehydrogenase activity enables early detection of liver injury in subjects with underlying muscle impairments
por: Schomaker, Shelli, et al.
Publicado: (2020) -
Phase I study of PF‐04895162, a Kv7 channel opener, reveals unexpected hepatotoxicity in healthy subjects, but not rats or monkeys: clinical evidence of disrupted bile acid homeostasis
por: Aleo, Michael D., et al.
Publicado: (2019) -
The MicroRNA-based Liquid Biopsy Improves Early Assessment of Lethal Acetaminophen Poisoning: A Case Report
por: Krauskopf, Julian, et al.
Publicado: (2020)